罗子君险些没了“后半生”,用酒送服安眠药有这么危险吗

2017-07-12 石浩强/上海交通大学医学院附属瑞金医院 澎湃新闻

电视剧《我的前半生》正在热播,第九集中马伊琍扮演的失婚家庭主妇罗子君用酒服下了两片安眠药,导致一睡不醒,被贺涵送到了医院洗胃。医生想说,你这样吃安眠药,不是自杀是什么!?我们不明真相的观众也有满满的疑惑,用酒送服安眠药到底有啥后果?吃了安眠药会叫不醒?问题可真的严重了,一不小心就真的变成了“自杀” !镇静催眠药是一类可抑制中枢神经系统的药物,一般小剂量镇静,中等剂量则可引起类似于生理性睡眠的催眠作

电视剧《我的前半生》正在热播,第九集中马伊琍扮演的失婚家庭主妇罗子君用酒服下了两片安眠药,导致一睡不醒,被贺涵送到了医院洗胃。医生想说,你这样吃安眠药,不是自杀是什么!?

我们不明真相的观众也有满满的疑惑,用酒送服安眠药到底有啥后果?吃了安眠药会叫不醒?

问题可真的严重了,一不小心就真的变成了“自杀” !

镇静催眠药是一类可抑制中枢神经系统的药物,一般小剂量镇静,中等剂量则可引起类似于生理性睡眠的催眠作用,大剂量则会产生麻醉和抗惊厥作用。服用镇静催眠药的患者需忌酒或含有酒精的饮料,因为酒精可能会加重药物对中枢神经系统的抑制作用,使不良反应加大,甚至导致死亡。

一般思诺思最大剂量为一次一片,而罗子君一次服下两片,已经过量,再加上大半杯烈酒,危险随之产生了……

现实生活中也有不少这样的案例,比如香港明星陈百强,也因服用安眠药后大量饮酒,昏迷30多天后辞世。所以,有服用安眠药习惯的朋友们,一定要避免与酒同服。

罗子君拿了艾司唑仑和思诺思两种安眠药,仔细挑选一番之后选择了思诺思,那么这两种安眠药有什么不同吗?

艾司唑仑

属于苯二氮卓类镇静催眠药,对于入睡困难及易醒者皆有效。苯二氮卓类药物的停药反应较轻,治疗指数较高,安全性更好,几乎无肝药酶诱导作用,不影响其他药物的代谢,依赖性与戒断症状也较轻。常见的不良反应有“宿醉”现象(即类似于过量饮酒的直接后作用导致的醉酒后状态)、损害记忆功能等,而长期应用还可产生耐受性、依赖性,久服突然停药会出现戒断症状,如焦虑、失眠、震颤、心动过速等。

思诺思

属于非苯二氮卓类的镇静催眠药,此类镇静催眠药能明显地缩短入睡时间、延长睡眠时间,提高睡眠质量。半衰期短,安全性更好,几乎无“宿醉”不良反应,成瘾性与戒断反应发生也较少,适用于入睡困难者和病理基础的失眠者及考前应急性失眠者。

镇静催眠药一定要在医生的指导下使用,切忌擅自服用!另外,有些药物和食物是“冤家”,千万不可同时服用。

小贴士:不可同服的食物与药物

头孢菌素类药物(如头孢哌酮、头孢曲松、头孢西丁、头孢呋辛等)、甲硝唑、酮康唑、华法林、肝素、阿司匹林、镇静催眠药等在用药期间需忌酒。

铁剂、黄连素在服药时,不宜饮茶或用茶水送服。

甲磺酸双氢麦角毒碱、舍曲林、降压药物(如苯磺酸氨氯地平、非洛地平、贝尼地平、硝苯地平等)、伊曲康唑等不宜与葡萄柚汁同服。

钙剂不宜与富含纤维素(例如菠菜)、咖啡因的食物(例如咖啡、可乐)同服。

一般需服药后间隔1-2小时再喝牛奶。

苦瓜有一定的降血糖作用,在与那格列奈、吡格列酮合用时,会增加低血糖发生的风险。

盐酸金刚烷胺、氟哌啶醇不宜与槟榔同服。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1486292, encodeId=fef714862927e, content=<a href='/topic/show?id=316245826ec' target=_blank style='color:#2F92EE;'>#安眠药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45826, encryptionId=316245826ec, topicName=安眠药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89cf8112748, createdName=ms3046638856685384, createdTime=Fri Jul 14 08:34:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221620, encodeId=04b3221620c6, content=好危险!, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2SEXGDldsNfP4rKvY7vJmaHcyvLXicuyaCTJtVOkX3jvd6DwNMD88hDjJwsU7MnUH6zeqC4zt3yGV/0, createdBy=4e701628585, createdName=flyingzyx, createdTime=Thu Jul 13 06:00:03 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221602, encodeId=dca22216028a, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Thu Jul 13 00:24:04 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221584, encodeId=e68c2215840a, content=学习了谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Thu Jul 13 00:11:04 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221580, encodeId=6b5e2215802c, content=那是可能送命的, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Thu Jul 13 00:09:47 CST 2017, time=2017-07-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1486292, encodeId=fef714862927e, content=<a href='/topic/show?id=316245826ec' target=_blank style='color:#2F92EE;'>#安眠药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45826, encryptionId=316245826ec, topicName=安眠药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89cf8112748, createdName=ms3046638856685384, createdTime=Fri Jul 14 08:34:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221620, encodeId=04b3221620c6, content=好危险!, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2SEXGDldsNfP4rKvY7vJmaHcyvLXicuyaCTJtVOkX3jvd6DwNMD88hDjJwsU7MnUH6zeqC4zt3yGV/0, createdBy=4e701628585, createdName=flyingzyx, createdTime=Thu Jul 13 06:00:03 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221602, encodeId=dca22216028a, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Thu Jul 13 00:24:04 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221584, encodeId=e68c2215840a, content=学习了谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Thu Jul 13 00:11:04 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221580, encodeId=6b5e2215802c, content=那是可能送命的, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Thu Jul 13 00:09:47 CST 2017, time=2017-07-13, status=1, ipAttribution=)]
    2017-07-13 flyingzyx

    好危险!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1486292, encodeId=fef714862927e, content=<a href='/topic/show?id=316245826ec' target=_blank style='color:#2F92EE;'>#安眠药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45826, encryptionId=316245826ec, topicName=安眠药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89cf8112748, createdName=ms3046638856685384, createdTime=Fri Jul 14 08:34:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221620, encodeId=04b3221620c6, content=好危险!, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2SEXGDldsNfP4rKvY7vJmaHcyvLXicuyaCTJtVOkX3jvd6DwNMD88hDjJwsU7MnUH6zeqC4zt3yGV/0, createdBy=4e701628585, createdName=flyingzyx, createdTime=Thu Jul 13 06:00:03 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221602, encodeId=dca22216028a, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Thu Jul 13 00:24:04 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221584, encodeId=e68c2215840a, content=学习了谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Thu Jul 13 00:11:04 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221580, encodeId=6b5e2215802c, content=那是可能送命的, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Thu Jul 13 00:09:47 CST 2017, time=2017-07-13, status=1, ipAttribution=)]
    2017-07-13 130****4638

    学习了谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1486292, encodeId=fef714862927e, content=<a href='/topic/show?id=316245826ec' target=_blank style='color:#2F92EE;'>#安眠药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45826, encryptionId=316245826ec, topicName=安眠药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89cf8112748, createdName=ms3046638856685384, createdTime=Fri Jul 14 08:34:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221620, encodeId=04b3221620c6, content=好危险!, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2SEXGDldsNfP4rKvY7vJmaHcyvLXicuyaCTJtVOkX3jvd6DwNMD88hDjJwsU7MnUH6zeqC4zt3yGV/0, createdBy=4e701628585, createdName=flyingzyx, createdTime=Thu Jul 13 06:00:03 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221602, encodeId=dca22216028a, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Thu Jul 13 00:24:04 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221584, encodeId=e68c2215840a, content=学习了谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Thu Jul 13 00:11:04 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221580, encodeId=6b5e2215802c, content=那是可能送命的, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Thu Jul 13 00:09:47 CST 2017, time=2017-07-13, status=1, ipAttribution=)]
    2017-07-13 惠映实验室

    学习了谢谢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1486292, encodeId=fef714862927e, content=<a href='/topic/show?id=316245826ec' target=_blank style='color:#2F92EE;'>#安眠药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45826, encryptionId=316245826ec, topicName=安眠药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89cf8112748, createdName=ms3046638856685384, createdTime=Fri Jul 14 08:34:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221620, encodeId=04b3221620c6, content=好危险!, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2SEXGDldsNfP4rKvY7vJmaHcyvLXicuyaCTJtVOkX3jvd6DwNMD88hDjJwsU7MnUH6zeqC4zt3yGV/0, createdBy=4e701628585, createdName=flyingzyx, createdTime=Thu Jul 13 06:00:03 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221602, encodeId=dca22216028a, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Thu Jul 13 00:24:04 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221584, encodeId=e68c2215840a, content=学习了谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Thu Jul 13 00:11:04 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221580, encodeId=6b5e2215802c, content=那是可能送命的, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Thu Jul 13 00:09:47 CST 2017, time=2017-07-13, status=1, ipAttribution=)]
    2017-07-13 飛歌

    那是可能送命的

    0

相关资讯

J Watch评价:安眠药可预防谵妄吗?

一种褪黑素受体激动剂在老年急性住院患者中反应为阳性。 谵妄是严重疾病的一种常见并发症,尤其在老年和痴呆患者中。褪黑素被发现有助减少谵妄风险,病例报告褪黑素1和2受体激动剂雷美替胺也可以。为了解更多关于雷美替胺在预防谵妄方面的作用,来自日本的研究人员进行了一项5家医院参与的、随机、安慰剂对照试验,在67例因脑卒中、感染、骨折、心脏病或其他疾病住院的急性重症患者(平均78岁)中使用雷美替胺(8m

SLEEP:儿童血铅水平对其今后睡眠质量的影响

目的: 很少人知道铅暴露对儿童睡眠的影响。这项研究旨在探究血铅水平(BLL)与儿童睡眠问题关系的纵向研究。 方式: 研究在中国金坛市四个社区小学进行。参与者共有1419名儿童。研究人员检测参与者的BLL水平时他们的年龄为3-5岁,并在他们9-13岁时评估了他们的睡眠质量。在评估睡眠质量时,研究人员不仅咨询参与者的父母及本人收集信息,同时采用CSHQ量表。一共665名儿童完成BLL水平检测和睡眠评估

FDA全新警告:止痛药+安眠药 死亡危险高

导语:近日,美国食品及药物管理局(FDA)再次发出警告,把阿片类止痛药或止咳药和苯二氮卓类镇静剂混合在一起服用非常危险,可能导致昏迷或死亡的致命后果。同时,FDA建议对近400种药品使用最高级别的黑框警告,让医生和病人了解如果将这两种药物混合使用,那么将会导致失眠、呼吸缓慢,甚至导致昏迷、死亡。因此,FDA表示,发出这个警告是为了减少因为滥用阿片类止痛药而导致的死亡事件。此外,FDA委员卡里夫表示

BMJ:安定类安眠药或增加痴呆风险

 一项最新发表在《英国医学杂志》(BMJ 2012;345:e6231.)的研究显示,服用安定类(苯二氮卓类)安眠药需慎重,因为它可能增加患痴呆症的风险。   研究称,法国和美国研究人员对一千多名平均年龄为78岁的老人进行了为期15年的跟踪调查。调查开始时,这些老人都没有痴呆症状。后来其中部分人开始服用安定类安眠药,结果显示,这部分人出现痴呆症的风险比其他人高60%。   

SCI TRANSL MED :嗜睡者脑脊髓液中一物质似安眠药

来自埃默里大学医学院的研究人员发现数十名对睡眠具有高需求的成年人脑脊髓液中有一种物质能像安眠药一样起作用。研究结果在线发表在11月21日的《科学—转化医学》(Science Translational Medicine)杂志上。 这一患者群的一些成员似乎患有一种称作“原发性嗜睡症”的独特的令人丧失能力的睡眠紊乱疾病,其不同于众所周知的睡眠呼吸暂停综合症(sleep apnea)或发作性睡

嗜睡者脑脊液发现“安眠”物质

  来自埃默里大学医学院的研究人员发现数十名对睡眠具有高需求的成年人脑脊液中有一种物质能像安眠药一样起作用。研究结果在线发表在11月21日的《科学—转化医学》(Science Translational Medicine)杂志上。   这一患者群的一些成员似乎患有一种称作“原发性嗜睡症”的独特的令人丧失能力的睡眠紊乱疾病,其不同于众所周知的睡眠呼吸暂停综合征(sleep apnea)或发作性睡眠